ST宁科：原大股东上海中能持股数量占比由29.20%下降为12.38%

Core Points - ST Ningke announced a capital increase plan for Ningke Biology, converting 931 million shares based on a ratio of 13.593 shares for every 10 shares held, resulting in a total share capital of 1,615,883,775 shares [1] - The newly issued shares will not be distributed to existing shareholders; 882,970,129 shares will be allocated to new restructuring investors, while 48,029,871 shares will be used to settle debts with creditors of Ningke Biology and its subsidiaries [1] - Following the restructuring, Shanghai Zhongneng's shareholding will remain unchanged, but its ownership percentage will decrease from 29.20% to 12.38% of the total share capital [1]